课题基金 / 基金详情

Blood Exposures Among Workers at the Clinical Center and Four Hospitals in Japan

Blood Exposures Among Workers at the Clinical Center and Four Hospitals in Japan
日本临床中心和四家医院工作人员的血液暴露
批准号:
6431890
负责人:
DAVID C HENDERSON
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

DAVID C HENDERSON的其他基金

相似基金

相关文献

中文摘要
翻译
本研究的目的是(1)评价和比较日本四所大学医院和国立卫生研究院临床中心的护士在流行病学、发病机理、职业风险和适当预防策略方面的知识,以管理在医疗环境中感染血源性病原体的患者;(2)比较自我报告的遵守现有感染控制建议的水平,这些建议旨在限制所有八个机构暴露于血源性病原体的风险;(3)比较研究中五家医院自我报告的血液皮肤暴露频率;(4)评估教育干预对护士对建议的依从性和自我报告的血液暴露频率的影响。大约2,000名日本人和500名临床中心护士完成了初步调查。初步数据分析表明,所研究的医院之间对血源性病原体的了解存在显着差异,并且血液暴露频率也存在相应差异。已经设计了一项教育干预措施,第一阶段已经实施。日本和美国的护士将于2001年初重新接受调查。
英文摘要
This study is designed (1) to evaluate and compare nurses knowledge of the epidemiology, pathogenesis, occupational risks, and appropriate prevention strategies for managing patients infected with bloodborne pathogens in the healthcare setting in four university hospitals in Japan and at the Clinical Center of the National Institutes of Health; (2) to compare self-reported levels of compliance with existing infection control recommendations designed to limit risk for exposure to bloodborne pathogens in all eight institutions; (3) to compare self-reported frequencies of cutaneous exposures to blood at the five hospitals in the study; and (4) to evaluate the effect of educational intervention on nurses perceived compliance with recommendations and on the frequency of self-reported exposures to blood.Approximately 2,000 Japanese and 500 Clinical Center nurses have completed the initial survey. Preliminary data analysis demonstrates a substantial difference in knowledge about bloodborne pathogens and a corresponding difference in frequency of blood exposures between the hospitals studied. An educational intervention has been designed and the first phase has been implemented. Nurses from Japan and the United States will be resurveyed in early 2001.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: ARIPIPRAZOLE FOR CLOZAPINE ASSOCIATED MEDICAL MORBIDITY
  • 批准号:
    7731263
  • 项目类别:
  • 资助金额:
    $0.45万
  • 财政年份:
    2008
  • 负责人:
    DAVID C HENDERSON
  • 依托单位:
ARIPIPRAZOLE FOR CLOZAPINE ASSOCIATED MEDICAL MORBIDITY
  • 批准号:
    7731320
  • 项目类别:
  • 资助金额:
    $0.26万
  • 财政年份:
    2008
  • 负责人:
    DAVID C HENDERSON
  • 依托单位:
ARIPIPRAZOLE FOR CLOZAPINE ASSOCIATED MEDICAL MORBIDITY
  • 批准号:
    7607075
  • 项目类别:
  • 资助金额:
    $1.25万
  • 财政年份:
    2006
  • 负责人:
    DAVID C HENDERSON
  • 依托单位:
ROSIGLITAZONE FOR CLOZAPINE INDUCED GLUCOSE METABOLISM IMPAIRMENT
  • 批准号:
    7607033
  • 项目类别:
  • 资助金额:
    $0.03万
  • 财政年份:
    2006
  • 负责人:
    DAVID C HENDERSON
  • 依托单位:
海外基金